glp-1 news october 21 2025 New Pill Foundayo (Orforglipron) Gets FDA Approval for Obesity GLP-1 Coverage Debate Comes Down

Recommendations for quantitative analysis of small molecules by matrix-assisted laser desorption ionization mass spectrometry

GHK-Cu Research Foundation Research by Dr

Maintain a healthy lifestyle to prolong your glow

Another recently completed phase 3 clinical trial called REDEFINE 2 , which included 1,207 adults with type 2 diabetes and overweight or obesity, found that after 68 weeks, CagriSema led to weight loss of almost 16% experts say the highest yet in the type 2 population, compared to other weight management drugs like tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) and semaglutide

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

When you eat, GLP-1 is produced by your intestines to help you feel full, but we normally dont have high levels of GLP-1 circulating in our bloodstream